•
Jun 30, 2017

ResMed Q4 2017 Earnings Report

Total Revenue
$557M
Previous year: $519M
+7.3%
EPS
$0.77
Previous year: $0.74
+4.1%
Gross Profit
$324M
Previous year: $301M
+7.4%
Cash and Equivalents
$822M
Previous year: $731M
+12.4%
Free Cash Flow
$122M
Previous year: $534M
-77.1%
Total Assets
$3.47B
Previous year: $3.26B
+6.5%

ResMed

ResMed